Clinical trials
Phase 1/2 Pancreatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
| Recruiting | 6 |
| Completed | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amplia Therapeutics Limited | 2 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
| AmMax Bio, Inc. | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| ENB Therapeutics, Inc | 1 |
| Eli Lilly and Company | 1 |
| Filamon LTD | 1 |
| Frontier Medicines Corporation | 1 |
| Immix Biopharma Australia Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 19 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 9 |
| Ovarian Neoplasms | 9 |
| Breast Neoplasms | 6 |
| Prostatic Neoplasms | 6 |
| Endometrial Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.